Cipher Pharmaceuticals Inc.TSX: CPH

Cipher Receives Health Canada Approval of (Pr)Beteflam(TM)

· Issued by Cipher Pharmaceuticals Inc. via CNW

Investors: In Canada: Craig Armitage, LodeRock Advisors, (416) 347-8954, [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, [email protected]; Media: Mike Beyer, Sam Brown Inc., (312) 961-2502, [email protected] CNW Group 2015

View original source (CNW)Cipher Pharmaceuticals Inc. on 6ix

Story so far

Earlier from Cipher Pharmaceuticals

Later from Cipher Pharmaceuticals

All Cipher Pharmaceuticals news releases